Affordable Access

Publisher Website

An liquid chromatography–tandem mass spectrometry assay for determination of trace amount of new antifungal drug iodiconazole in human plasma

Authors
Journal
Journal of Chromatography B
1570-0232
Publisher
Elsevier
Publication Date
Volume
877
Issue
4
Identifiers
DOI: 10.1016/j.jchromb.2008.12.034
Keywords
  • Iodiconazole
  • Lc–Ms/Ms
  • Antifungal Drug
  • Human Plasma

Abstract

Abstract A simple, rapid and sensitive LC–MS/MS method for determination of trace amount of new antifungal drug iodiconazole in human plasma was developed (1-(1H-1,2,4-triazole)-2-(2,4-diflurophenyl)-3-[ N-methyl- N-(3-chlor-benzyl)amino]-2-propanol), was used as internal standard (IS). The analytes were extracted by liquid–liquid extraction with n-hexane after internal standard spiked. The separation was performed by a ZORBAX SB-C 18 column (3.5 μm, 2.1 mm × 100 mm) with an isocratic mobile phase consisting of methanol–water–formic acid (50:50:0.05, v/v/v) at a flow rate of 0.3 mL/min. The lower limit of quantification (LLOQ) was 0.10 ng/mL. This method was successfully used to determine the concentration of iodiconazole in human plasma following dermal administration.

There are no comments yet on this publication. Be the first to share your thoughts.